Skip to main content
Log in

Influence of epidermal growth factor on photodynamic therapy of glioblastoma cells in vitro

  • Published:
Research in Experimental Medicine

Abstract

Photodynamic therapy (PDT) could be a useful adjuvant in glioblastoma treatment. The fact that epidermal growth factor (EGF) and its receptor are involved in glioblastoma growth control led us to investigate the relationships between EGF and PDT with respect to three different glioma cell lines (C6, T98 G, U87 MG) responsive to growth stimulation by EGF. Flow cytometric analysis revealed that each cell line expressed EGF receptors. PDT was then applied to the cells using haematoporphyrin derivative (HPD) as photosensitizer and argon laser irradiation. When cells were incubated for 2 h with HPD (0.1–10 μg/ml) and then laser-irradiated (λ = 514 nm; energy density 25 J/cm2), all three cell lines showed photosensitivity. The median lethal dose was respectively 3, 4.5 and 2.7 μg/ml for C6, T98 G and U87 MG. EGF (2–50 ng/ml) had no effect on HPD- and laser-induced toxicity when added to cells before PDT, whereas toxicity decreased for all three cell lines when EGF was added after PDT. HPD (1–2 μg/ml, incubation times 30–180 min) also induced an increase in EGF receptor expression for the C6 line.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Adachi K, Belser P, Bender H, Li D, Rodeck U, Benveniste EN, Woo D, Schmiegel WH, Herlyn D (1992) Enhancement of epidermal growth factor receptor expression on glioma cells by recombinant tumor necrosis factor alpha. Cancer Immunol Immunother 34: 370–376

    Article  CAS  PubMed  Google Scholar 

  2. Bellot F, Moolenar W, Kris R, Mirakhur B, Verlaan I, Ullrich A, Schlessinger J, Felder S (1990) High-affinity epidermal growth factor binding is specifically reduced by a monoclonal antibody and appears necessary for early responses. J Cell Biol 110: 491–502

    Article  CAS  PubMed  Google Scholar 

  3. Berkers JAM, Van Bergen en Henegouwen PMP, Boonstra J (1991) Three classes of epidermal growth factor receptors on HeLa cells. J Biol Chem 266: 922–927

    CAS  PubMed  Google Scholar 

  4. Blagoveshchenskaia AD, Sokolova IP, Kornilova ES, Nikol’skii NN (1994) The dependence of the endocytosis of the epidermal growth factor receptors on the degree of receptor occupancy. Tsitologiia 36: 664–674

    CAS  PubMed  Google Scholar 

  5. Carpenter G, Cohen S (1976) 125I-Labeled human epidermal growth factor: binding, internalisation and degradation in human fibroblasts. J Cell Biol 71: 159–171

    Article  CAS  PubMed  Google Scholar 

  6. Chaffanet M, Chauvin C, Laine M, Berger F, Chedin M, Rost N, Nissou MF, Benebid AL (1992) EGF receptor amplification and expression in human brain tumours. Eur J Cancer 28: 11–17

    Article  CAS  PubMed  Google Scholar 

  7. Davis C, Western A, Lindmo T, Moan J (1986) Changes in antigen expression on human melanoma cells after exposure to photoactivated hematoporphyrin derivative. Cancer Res 46: 60–68

    Google Scholar 

  8. Diamond I, Granelli SG, McDonagh AF, Nielsen S, Wilson CB, Jaenicke R (1972) Photodynamic therapy of malignant tumors. Lancet 2: 1175–1177

    Article  CAS  PubMed  Google Scholar 

  9. Dougherty TJ (1986) Photosensitization of malignant tumors. J Surg Oncol 2: 24–37

    CAS  Google Scholar 

  10. Fingar VH, Wieman J, Doak KW (1990) Role of thromboxane and prostaglandin release on photodynamic therapy induced tumour destruction. Cancer Res 50: 2599–2603

    CAS  PubMed  Google Scholar 

  11. Fukuyama R, Minoshima S, Ochiai A, Tahara E, Shimizu N (1991) Flow cytometric analysis of the expression of 9A3 antigen, E-cadherin and EGF receptor in TMK-1 stomach cancer cells. Int J Cancer 48: 81–84

    Article  CAS  PubMed  Google Scholar 

  12. Gamou S, Shimizu N (1987) Change in metabolic turnover is an alternate mechanism increasing cell surface epidermal growth factor receptor levels in tumor cells. J Biol Chem 262: 6708–6713

    CAS  PubMed  Google Scholar 

  13. Glinski JA, David E, Warren TC, Hansen G, Leonard SF, Pitner P, Pav S, Arvigo R, Balick MJ, Panti E, Grob PM (1995) Inactivation of cell surface receptors by pheophorbide a, a green pigment isolated from Psychotria acuminata. Photochem Photobiol 62: 144–150

    Article  CAS  PubMed  Google Scholar 

  14. Gregorie HB (1968) Hematoporphyrin derivative fluorescence in malignant neoplasms. Ann Surg 167: 820

    Article  PubMed Central  PubMed  Google Scholar 

  15. Hemming AW, Davis NL, Dubois B, Quenville NF, Finley RJ (1993) Photodynamic therapy of squamous cell carcinoma: an evaluation of a new photosensitizing agent, benzoporphyrin derivative, and new photoimmunoconjugate. Surg Oncol 2: 187–196

    Article  CAS  PubMed  Google Scholar 

  16. Hirai M, Gamou S, Minoshima S, Shimizu N (1988) Two independent mechanisms for escaping epidermal growth factor-mediated growth inhibition in epidermal growth factor receptor hyperproducing human tumor cells. J Cell Biol 107: 791–799

    Article  CAS  PubMed  Google Scholar 

  17. Hoi Sang U, Espiritu OD, Kelley PY, Klauber MR, Hatton JD (1995) The role of the epidermal growth factor receptor in human gliomas. I. The control of cell growth. J Neurosurg 82: 841–846

    Article  CAS  PubMed  Google Scholar 

  18. Hurtt MR, Moossy J, Donovan-Peluso M, Locker J (1992) Amplification of epidermal growth factor receptor gene in gliomas: histopathology and prognosis. J Neuropathol Exp Neurol 51: 84–90

    Article  CAS  PubMed  Google Scholar 

  19. Kaye AH, Hill JS (1993) Photodynamic therapy of brain tumours. Ann Acad Med Singapore 22: 470–481

    CAS  PubMed  Google Scholar 

  20. Kaye AH, Morstyn G (1987) Photoradiation therapy causing selective tumor kill in a rat glioma model. Neurosurgery 20: 408–415

    Article  CAS  PubMed  Google Scholar 

  21. Kessel D (1986) Photosensitization with derivatives of haematoporphyrin. Int J Radiat Biol 49: 901–907

    Article  CAS  Google Scholar 

  22. Kostron H, Fritsch E, Grunert V (1988) Photodynamic therapy of malignant brain tumors: a phase I–II trial. Br J Neurosurg 2: 241–248

    Article  CAS  PubMed  Google Scholar 

  23. Lajat Y, Patrice T (1987) Photochemotherapy applied stereotactically to brain tumors. Surg Neurol 11: 14

    Google Scholar 

  24. Leunig A, Staub F, Peters J, Leiderer R, Feyh J, Goetz A (1994) Damage to tumor cells by photodynamic therapy. Laryngorhinootologie 73: 102–107

    Article  CAS  PubMed  Google Scholar 

  25. Miller CC, Hale P, Pentland AP (1994) Ultraviolet B injury increases prostaglandin synthesis through a tyrosine kinase-dependent pathway: evidence for UVB-induced epidermal growth factor receptor activation. J Biol Chem 269: 3529–3533

    CAS  PubMed  Google Scholar 

  26. Murphy S, Welk G, Thwin SS (1990) Stimulation of thromboxane release from primary cell cultures derived from human astrocytic glioma biopsies. Glia 3: 205–211

    Article  CAS  PubMed  Google Scholar 

  27. Noske DP, Wolbers JG, Sterenborg HJCM (1991) Photodynamic therapy of malignant glioma: a review of literature. Clin Neurol Neurosurg 93: 293–307

    Article  CAS  PubMed  Google Scholar 

  28. Palombella VJ, Yamashiro DJ, Maxfield FR, Decker SJ, Vilcek J (1987) Tumor necrosis factor increases the number of epidermal growth factor receptors on human fibro-blasts. J Biol Chem 262: 1950–1954

    CAS  PubMed  Google Scholar 

  29. Perria C, Capuzzo T, Cavagnaro G (1980) First attempts at the photodynamic treatment of human gliomas. J Neurosurg Sci 24: 119–129

    CAS  PubMed  Google Scholar 

  30. Perria C, Carai M, Falzoi A (1988) Photodynamic therapy of malignant brain tumors: clinical results of, difficulties with, questions about, and future prospects for the neurosurgical applications. Neurosurgery 23: 557–563

    Article  CAS  PubMed  Google Scholar 

  31. Pollack IF, Randall MS, Kristofik MP, Kelly RH, Selker RG, Vertosick FT (1990) Response of malignant glioma cell lines to epidermal growth factor and platelet-derived growth factor in a serum-free medium. J Neurosurg 73: 106–112

    Article  CAS  PubMed  Google Scholar 

  32. Powers SK, Cusch SS, Walstad DL, Kwock L (1991) Stereotactic intratumoral photo-dynamic therapy for recurrent malignant brain tumors. Neurosurgery 29: 688–696

    Article  CAS  PubMed  Google Scholar 

  33. Pulver M, Zuber P, de Tribolet N (1987) Immonubiologie de l’astrocyte normal et tumoral. Rev Neurol 143: 711–721

    CAS  PubMed  Google Scholar 

  34. Reifenberger J, Ring GU, Gies U, Cobbers L, Oberstrass J, An HX, Niederacher D, Wechsler W, Reifenberger G (1996) Analysis of p53 mutation and epidermal growth factor receptor amplification in recurrent gliomas with malignant progression. J Neuropathol Exp Neurol 55: 822–831

    Article  CAS  PubMed  Google Scholar 

  35. Sauter G, Maeda T, Waldman FM, Davis RL, Feuerstein BG (1996) Patterns of epidermal growth factor receptor amplification in malignant gliomas. Am J Pathol 148: 1047–1053

    CAS  PubMed Central  PubMed  Google Scholar 

  36. Schick E, Kaufmann R, Ruck A, Hainzl A, Boehncke WH (1995) Influence of activation and differentiation of cells on the effectiveness of photodynamic therapy. Acta Derm Venereol 75: 276–279

    CAS  PubMed  Google Scholar 

  37. Schlegel J, Merdes A, Stumm G, Albert FK, Forsting M, Hynes N, Kiessling M (1994) Amplification of the epidermal growth factor receptor gene correlates with different growth behaviour in human glioblastoma. Int J Cancer 56: 72–77

    Article  CAS  PubMed  Google Scholar 

  38. Shapiro JR (1986) Biology of gliomas: heterogeneity, oncogenes, growth factors. Semin Oncol 13: 4–15

    CAS  PubMed  Google Scholar 

  39. St-Pierre PR, Petersen NO (1992) Average density and size of microclusters of epidermal growth factor receptors on A431 cells. Biochemistry 31: 2459–2463

    Article  CAS  PubMed  Google Scholar 

  40. Stein GH (1979) T98G: an anchorage independent human tumor cell line that exhibits stationary phase G1 arrest in vitro. J Cell Physiol 99: 43–54

    Article  CAS  PubMed  Google Scholar 

  41. Tuzi NL, Venter DJ, Kumar S, Staddon SL, Lemoine NR, Gullick WJ (1991) Expression of growth factor receptors in human brain tumors. Br J Cancer 63: 227–233

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  42. Vonarx-Coinsmann V (1994) Photochimiothérapie et immunité cellulaire spécifique. Doctoral dissertation, University of Nantes, France

    Google Scholar 

  43. Werner MH, Humphrey PA, Bigner DD, Bigner SH (1988) Growth effects of epidermal growth factor and a monoclonal antibody against the EGF receptor on four glioma cell lines. Acta Neuropathol 77: 196–201

    CAS  PubMed  Google Scholar 

  44. Wharen RE, So S, Anderson RE, Laws ER (1986) Hematoporphyrin derivative photo-cytotoxicity of human glioblastoma in cell culture. Neurosurgery 19: 495–501

    Article  PubMed  Google Scholar 

  45. Wikstrand CJ, Hale LP, Batra SK, Hill ML, Humphrey PA, Kurpad SN, McLendon RE, Moscatello D, Pegram CN, Reist CJ, Traweek T, Wong AJ, Zalutsky MR, Bigner DD (1995) Monoclonal antibodies against EGFRvIII are tumor specific and react with breast and lung carcinomas and malignant gliomas. Cancer Res 55: 3140–3148

    CAS  PubMed  Google Scholar 

  46. Youle RJ (1996) Immunotoxins for central nervous system malignancy. Semin Cancer Biol 7: 65–70

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Fanuel-Barret, D., Patrice, T., Foultier, MT. et al. Influence of epidermal growth factor on photodynamic therapy of glioblastoma cells in vitro. Res. Exp. Med. 197, 219–233 (1997). https://doi.org/10.1007/s004330050071

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s004330050071

Key words

Navigation